Allo, Gabriel
ORCID: 0000-0001-7568-7431, Quickert, Stefanie
ORCID: 0009-0009-9391-4111, Große, Karsten, Baysal, Sidar
ORCID: 0009-0001-5769-4096, Nierhoff, Dirk
ORCID: 0000-0001-7297-2675, Neumann-Haefelin, Christoph
ORCID: 0000-0001-7351-1387, Schramm, Christoph, Bruns, Tony
ORCID: 0000-0002-5576-6914, Reuken, Philipp Alexander
ORCID: 0000-0002-7696-475X and Bürger, Martin
ORCID: 0000-0002-8940-7696
(2025).
Acute Variceal Bleeding During the SARS-CoV-2 Pandemic: A National Multicenter Observational Study.
Journal of Clinical Medicine, 14 (17).
MDPI.
ISSN 2077-0383
|
PDF
jcm-14-06166-v2.pdf Bereitstellung unter der CC-Lizenz: Creative Commons Attribution. Download (484kB) |
Abstract
[Artikel-Nr. 6166] Background: The COVID-19 pandemic disrupted healthcare systems globally, raising concerns about its negative impact on patients with chronic liver diseases by contributing to hepatic decompensations such as acute variceal bleeding (AVB). This study aimed to evaluate the impact of the COVID-19 pandemic on clinical outcomes in cirrhotic patients with AVB in Germany. Methods: This retrospective national multicenter study compared patients with cirrhosis and AVB treated at four tertiary care centers in Germany before (2016–2020) and during the pandemic (2020–2022). The primary endpoint was 6-week mortality, and secondary outcomes included infections, transfusion requirement and rebleeding. Results: The baseline characteristics of the 247 patients were largely comparable between the two groups, however metabolic dysfunction-associated steatotic liver disease was more prevalent during the pandemic compared to the pre-pandemic period (12.5% vs. 4.8%, p = 0.048). Only one patient tested positive for SARS-CoV-2. Six-week mortality (32.2% vs. 30.1%; p = 0.767) and rebleeding rates (22.8% vs. 22.3%; p = 1.000) did not differ significantly between groups. Interestingly, intubation rates, length of stay on the intensive care unit, post AVB infection rates and types of infection were also comparable (all p > 0.05), while transjugular intrahepatic portosystemic shunt placement (TIPS) after bleeding was performed more frequently during the pandemic (23.2% vs. 11.3%, p = 0.019). Conclusions: Relevant patient-related AVB outcomes were unaffected during the COVID-19 pandemic. These findings suggest the resilience of critical AVB management practices in German tertiary centers. The increased use of TIPS and MASLD prevalence during the pandemic may reflect evolving clinical practice and patient profiles warranting further investigation.
| Item Type: | Article |
| Creators: | Creators Email ORCID ORCID Put Code Große, Karsten UNSPECIFIED UNSPECIFIED UNSPECIFIED Schramm, Christoph UNSPECIFIED UNSPECIFIED UNSPECIFIED |
| URN: | urn:nbn:de:hbz:38-800602 |
| Identification Number: | 10.3390/jcm14176166 |
| Journal or Publication Title: | Journal of Clinical Medicine |
| Volume: | 14 |
| Number: | 17 |
| Number of Pages: | 10 |
| Date: | 31 August 2025 |
| Publisher: | MDPI |
| ISSN: | 2077-0383 |
| Language: | English |
| Faculty: | Faculty of Medicine |
| Divisions: | Faculty of Medicine > Innere Medizin > Klinik für Gastroenterologie und Hepatologie |
| Subjects: | Medical sciences Medicine |
| Uncontrolled Keywords: | Keywords Language upper gastrointestinal bleeding ; cirrhosis ; portal hypertension ; COVID-19 ; pandemic ; acute variceal bleeding English |
| ['eprint_fieldname_oa_funders' not defined]: | Publikationsfonds UzK |
| Refereed: | Yes |
| URI: | http://kups.ub.uni-koeln.de/id/eprint/80060 |
Downloads
Downloads per month over past year
Altmetric
Export
Actions (login required)
![]() |
View Item |
https://orcid.org/0000-0001-7568-7431